Cita APA

Goldberg, S. B., Redman, M. W., Lilenbaum, R., Politi, K., Stinchcombe, T. E., Horn, L., . . . Gandara, D. R. (2020). Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non–Small-Cell Lung Cancer: Final Results From SWOG S1403. J Clin Oncol.

Chicago Style Citation

Goldberg, Sarah B., et al. "Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non–Small-Cell Lung Cancer: Final Results From SWOG S1403." J Clin Oncol 2020.

Cita MLA

Goldberg, Sarah B., et al. "Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non–Small-Cell Lung Cancer: Final Results From SWOG S1403." J Clin Oncol 2020.